Macquarie Group
MEDP icon

Macquarie Group’s Medpace MEDP Stock Holding History

Macquarie Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
+202
New +$93.2K ﹤0.01% 806
2025
Q4 		– Sell
-7,701
Closed -$3.96M – 1233
2025
Q3 		$3.96M Buy
+7,701
New +$3.36M ﹤0.01% 991
2025
Q1 		– Sell
-3,912
Closed -$1.3M – 1768
2024
Q4 		$1.3M Sell
3,912
-11,922
-75% -$4.04M ﹤0.01% 1302
2024
Q3 		$5.29M Sell
15,834
-14,661
-48% -$5.57M 0.01% 954
2024
Q2 		$12.6M Sell
30,495
-10,689
-26% -$4.23M 0.01% 765
2024
Q1 		$16.6M Buy
41,184
+11
+0% +$3.87K 0.02% 702
2023
Q4 		$12.6M Buy
41,173
+20,901
+103% +$5.64M 0.01% 776
2023
Q3 		$4.91M Sell
20,272
-3,921
-16% -$1M 0.01% 928
2023
Q2 		$5.81M Buy
+24,193
New +$5.03M 0.01% 896
2022
Q4 		– Sell
-567
Closed -$148K – 1974
2022
Q3 		$148K Sell
567
-377
-40% -$60.2K ﹤0.01% 1669
2022
Q2 		$141K Hold
944
– – ﹤0.01% 1785
2022
Q1 		$154K Hold
944
– – ﹤0.01% 1854
2021
Q4 		$205K Hold
944
– – ﹤0.01% 1757
2021
Q3 		$179K Hold
944
– – ﹤0.01% 1822
2021
Q2 		$167K Hold
944
– – ﹤0.01% 1834
2021
Q1 		$155K Sell
944
-631
-40% -$96.5K ﹤0.01% 1781
2020
Q4 		$219K Hold
1,575
– – ﹤0.01% 1640
2020
Q3 		$176K Hold
1,575
– – ﹤0.01% 1646
2020
Q2 		$147K Sell
1,575
-925
-37% -$78.7K ﹤0.01% 1632
2020
Q1 		$183K Hold
2,500
– – ﹤0.01% 1479
2019
Q4 		$210K Hold
2,500
– – ﹤0.01% 1587
2019
Q3 		$210K Sell
2,500
-2,600
-51% -$196K ﹤0.01% 1574
2019
Q2 		$334K Buy
+5,100
New +$294K ﹤0.01% 1441
2019
Q1 		– Sell
-1,000
Closed -$53K – 1889
2018
Q4 		$53K Sell
1,000
-300
-23% -$16.5K ﹤0.01% 1589
2018
Q3 		$78K Sell
1,300
-6,700
-84% -$366K ﹤0.01% 1641
2018
Q2 		$344K Buy
8,000
+4,600
+135% +$186K ﹤0.01% 1482
2018
Q1 		$119K Buy
+3,400
New +$124K ﹤0.01% 1840

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Macquarie Group's MEDP Position: Q2 2026 in Review

Macquarie Group opened a new position in Medpace (MEDP) in Q2 2026: 202 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #806 among its holdings. This is a return to the name: Macquarie Group previously reported a position in MEDP as recently as Q3 2025.

Macquarie Group first reported a position in MEDP in Q1 2018 and has held it in 27 quarters since. The position peaked at $16.6M in Q1 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Macquarie Group held 202 shares of Medpace worth $107K as of Q2 2026.
  • Medpace was a new Macquarie Group position in Q2 2026.
  • Medpace made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #806 holding.
  • Macquarie Group first reported a position in Medpace in Q1 2018 and has held it in 27 quarters since.
  • Macquarie Group's Medpace position peaked at $16.6M in Q1 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.